NORGESTIMATE AND ETHINYL ESTRADIOL

NORGESTIMATE AND ETHINYL ESTRADIOL was reported 4621 times

NORGESTIMATE AND ETHINYL ESTRADIOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ACCIDENTAL USE OF PLACEBO 2 0.1538
1 MURPHY'S SIGN POSITIVE 2 0.0541
2 PREGNANCY ON ORAL CONTRACEPTIVE 75 0.0286
3 EPIPLOIC APPENDAGITIS 3 0.0234
4 ACUTE MACULAR NEURORETINOPATHY 4 0.0234
5 BLOOD COPPER INCREASED 3 0.0169
6 GALLBLADDER CHOLESTEROLOSIS 7 0.0154
7 FALLOPIAN TUBE CANCER 2 0.0139
8 CHOLESTEROSIS 3 0.0117
9 HYPERADRENOCORTICISM 3 0.0109
10 CONGENITAL AORTIC STENOSIS 2 0.0099
11 HEPATIC ADENOMA 5 0.0097
12 BRACHIAL PLEXOPATHY 2 0.0090
13 CENTRAL VISION LOSS 2 0.0090
14 BRONCHOSCOPY 2 0.0084
15 MENSTRUAL CLOTS 2 0.0083
16 NASAL SEPTAL OPERATION 3 0.0083
17 BILIARY DYSKINESIA 14 0.0082
18 INTRACRANIAL VENOUS SINUS THROMBOSIS 8 0.0075
19 PREGNANCY ON CONTRACEPTIVE 10 0.0068
20 CHOLECYSTITIS CHRONIC 44 0.0066
21 RIGHT ATRIAL DILATATION 3 0.0059
22 GAIT SPASTIC 2 0.0058
23 WITHDRAWAL BLEED 4 0.0055
24 CYCLIC VOMITING SYNDROME 4 0.0055
25 ENDOMETRIAL THICKENING 3 0.0054
26 GALLBLADDER NON-FUNCTIONING 3 0.0053
27 NAIL PITTING 2 0.0051
28 METRORRHAGIA 86 0.0050
29 ALLERGY TO METALS 3 0.0049
30 PILOERECTION 5 0.0046
31 FIBROADENOMA OF BREAST 2 0.0044
32 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 6 0.0044
33 HYPOPLASTIC LEFT HEART SYNDROME 3 0.0044
34 CENTRAL SEROUS CHORIORETINOPATHY 3 0.0044
35 POLYMENORRHOEA 15 0.0043
36 OPHTHALMIC MIGRAINE 3 0.0043
37 BLOOD OESTROGEN DECREASED 3 0.0043
38 GALLBLADDER INJURY 8 0.0041
39 SLEEP PARALYSIS 6 0.0041
40 PELVIC INFLAMMATORY DISEASE 6 0.0040
41 FOCAL NODULAR HYPERPLASIA 2 0.0038
42 PRODUCT BLISTER PACKAGING ISSUE 4 0.0038
43 GALLBLADDER POLYP 3 0.0038
44 WISDOM TEETH REMOVAL 5 0.0038
45 MENSTRUATION IRREGULAR 101 0.0038
46 DYSMENORRHOEA 49 0.0037
47 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 3 0.0037
48 OLIGOMENORRHOEA 8 0.0037
49 PRODUCT SELECTION ERROR 4 0.0036
50 PREMENSTRUAL SYNDROME 5 0.0036
51 MENSTRUAL DISORDER 30 0.0036
52 ECZEMA EYELIDS 2 0.0036
53 HAEMORRHAGIC OVARIAN CYST 2 0.0035
54 MENORRHAGIA 68 0.0035
55 UTERINE PERFORATION 29 0.0034
56 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 14 0.0034
57 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 3 0.0034
58 ENDOSCOPY 2 0.0033
59 ACNE CYSTIC 10 0.0033
60 HYPOMENORRHOEA 9 0.0033
61 INAPPROPRIATE PRESCRIBING 2 0.0032
62 ENDOMETRIOSIS 15 0.0031
63 ALLERGIC OEDEMA 2 0.0031
64 INTERNAL INJURY 2 0.0031
65 MENSTRUATION DELAYED 31 0.0029
66 MAST CELL ACTIVATION SYNDROME 4 0.0028
67 ANTICONVULSANT DRUG LEVEL DECREASED 4 0.0028
68 GLUTEN SENSITIVITY 4 0.0028
69 MYOFASCIAL PAIN SYNDROME 2 0.0028
70 BILIARY COLIC 8 0.0027
71 GINGIVAL ULCERATION 2 0.0027
72 BREAST TENDERNESS 20 0.0027
73 CHLAMYDIAL INFECTION 2 0.0026
74 SUBSTANCE USE 4 0.0026
75 PRE-EXISTING CONDITION IMPROVED 16 0.0026
76 BACTERIAL VAGINOSIS 4 0.0026
77 CYSTITIS INTERSTITIAL 4 0.0025
78 DYSFUNCTIONAL UTERINE BLEEDING 3 0.0025
79 VAGINAL HAEMORRHAGE 104 0.0024
80 ABORTION MISSED 3 0.0024
81 ADNEXA UTERI PAIN 3 0.0023
82 COELIAC DISEASE 23 0.0023
83 INFUSION SITE BRUISING 5 0.0023
84 INTERMENSTRUAL BLEEDING 12 0.0021
85 BREAST ENLARGEMENT 7 0.0021
86 CEREBRAL THROMBOSIS 6 0.0021
87 OVARIAN CYST 21 0.0021
88 FOOD ALLERGY 16 0.0021
89 EYELID RASH 2 0.0020
90 GENERALISED ANXIETY DISORDER 3 0.0020
91 PRODUCT ADMINISTRATION INTERRUPTED 16 0.0020
92 PRODUCT SUBSTITUTION ISSUE 117 0.0020
93 UNINTENDED PREGNANCY 21 0.0020
94 HEAVY MENSTRUAL BLEEDING 18 0.0020
95 RECALLED PRODUCT ADMINISTERED 19 0.0020
96 CYSTIC FIBROSIS 11 0.0020
97 CORONARY ARTERY THROMBOSIS 4 0.0020
98 ENURESIS 8 0.0020
99 BENIGN BREAST NEOPLASM 2 0.0020
100 MEDICAL DEVICE DISCOMFORT 6 0.0020
101 ABNORMAL UTERINE BLEEDING 5 0.0019
102 POLYCYSTIC OVARIES 3 0.0019
103 OPTIC NERVE DISORDER 3 0.0019
104 MEDICAL DEVICE PAIN 4 0.0019
105 BINGE EATING 2 0.0019
106 INFECTIOUS MONONUCLEOSIS 4 0.0018
107 ECTOPIC PREGNANCY WITH CONTRACEPTIVE DEVICE 3 0.0018
108 SERUM FERRITIN DECREASED 3 0.0017
109 CHEMICAL BURN 2 0.0017
110 DISTRACTIBILITY 2 0.0017
111 NEPHROGENIC DIABETES INSIPIDUS 2 0.0017
112 FEAR OF DISEASE 3 0.0017
113 SINUS OPERATION 4 0.0017
114 WEIGHT ABNORMAL 4 0.0017
115 THROMBOPHLEBITIS SUPERFICIAL 5 0.0016
116 VULVOVAGINAL SWELLING 3 0.0016
117 HORMONE LEVEL ABNORMAL 8 0.0016
118 MOOD SWINGS 52 0.0016
119 LARGE INTESTINE INFECTION 2 0.0016
120 GALLBLADDER DISORDER 29 0.0016
121 PELVIC PAIN 29 0.0016
122 BREAST PAIN 17 0.0016
123 HYPERCOAGULATION 3 0.0016
124 MENOMETRORRHAGIA 3 0.0016
125 CHOLELITHIASIS 51 0.0016
126 DEVICE MISUSE 2 0.0015
127 CHOLECYSTECTOMY 17 0.0015
128 CHEILITIS 8 0.0015
129 PRODUCT PACKAGING ISSUE 14 0.0015
130 REBOUND ECZEMA 3 0.0015
131 CORNEAL ABRASION 2 0.0015
132 DILATATION VENTRICULAR 3 0.0014
133 CATAPLEXY 2 0.0014
134 COMPLICATION OF DEVICE INSERTION 28 0.0014
135 DERMATITIS ATOPIC 74 0.0014
136 APPENDICECTOMY 5 0.0014
137 VAGINAL DISCHARGE 14 0.0014
138 PULMONARY FUNCTION TEST DECREASED 6 0.0014
139 FEELING OF BODY TEMPERATURE CHANGE 8 0.0014
140 INITIAL INSOMNIA 14 0.0014
141 AFFECT LABILITY 13 0.0013
142 INFERTILITY 2 0.0013
143 CHRONIC GASTRITIS 3 0.0013
144 AMENORRHOEA 23 0.0013
145 ROSACEA 6 0.0013
146 SINUS PAIN 3 0.0013
147 ABORTION INDUCED 12 0.0013
148 VULVOVAGINAL MYCOTIC INFECTION 5 0.0013
149 CHOLECYSTITIS 15 0.0013
150 MOOD ALTERED 34 0.0012
151 ABDOMINAL PAIN LOWER 31 0.0012
152 CARTILAGE INJURY 3 0.0012
153 EDUCATIONAL PROBLEM 2 0.0012
154 MITRAL VALVE PROLAPSE 2 0.0012
155 ANXIETY DISORDER 4 0.0012
156 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 20 0.0012
157 LOWER RESPIRATORY TRACT CONGESTION 2 0.0012
158 LACTOSE INTOLERANCE 3 0.0012
159 MILIARIA 2 0.0012
160 DRUG TITRATION ERROR 3 0.0012
161 BREAST DISCHARGE 2 0.0011
162 HANGOVER 4 0.0011
163 MUSCLE CRAMP 2 0.0011
164 PANIC ATTACK 41 0.0011
165 YAWNING 3 0.0011
166 INJURY 79 0.0011
167 SKIN WEEPING 4 0.0011
168 DEVICE PLACEMENT ISSUE 4 0.0011
169 BREAST SWELLING 3 0.0011
170 PULMONARY EMBOLISM 106 0.0011
171 DRUG MONITORING PROCEDURE NOT PERFORMED 2 0.0011
172 ABDOMINAL RIGIDITY 3 0.0011
173 CLUMSINESS 3 0.0011
174 DYSPAREUNIA 5 0.0011
175 PRODUCT DOSE OMISSION 71 0.0011
176 EOSINOPHILIC OESOPHAGITIS 3 0.0011
177 HYPERTRICHOSIS 2 0.0011
178 AURA 2 0.0011
179 ELECTRIC SHOCK SENSATION 3 0.0011
180 SOMNAMBULISM 7 0.0011
181 ALCOHOL INTERACTION 2 0.0010
182 ABORTION 3 0.0010
183 VENOUS THROMBOSIS 4 0.0010
184 DECREASED INTEREST 6 0.0010
185 EYELID PAIN 2 0.0010
186 DEVICE DEPOSIT ISSUE 2 0.0010
187 IMPAIRED WORK ABILITY 21 0.0010
188 DERMATITIS PSORIASIFORM 2 0.0010
189 WEIGHT LOSS POOR 5 0.0010
190 IMPAIRED SELF-CARE 2 0.0010
191 MAJOR DEPRESSION 7 0.0010
192 DEEP VEIN THROMBOSIS 62 0.0010
193 FOOD CRAVING 5 0.0009
194 ABDOMINAL ADHESIONS 3 0.0009
195 SLEEP TERROR 4 0.0009
196 BILE DUCT STONE 3 0.0009
197 ESCHERICHIA URINARY TRACT INFECTION 4 0.0009
198 UTERINE HAEMORRHAGE 4 0.0009
199 PRODUCT DISPENSING ISSUE 4 0.0009
200 GENITAL HAEMORRHAGE 12 0.0009
201 BLOOD TESTOSTERONE INCREASED 2 0.0009
202 GASTRIC CANCER STAGE IV 2 0.0009
203 TENSION HEADACHE 4 0.0009
204 ABSCESS INTESTINAL 2 0.0009
205 BRUXISM 5 0.0009
206 PHARMACEUTICAL PRODUCT COMPLAINT 24 0.0009
207 VITAMIN D DEFICIENCY 9 0.0009
208 BIPOLAR DISORDER 10 0.0009
209 GASTRIC BYPASS 2 0.0009
210 PRODUCT FORMULATION ISSUE 6 0.0009
211 LYME DISEASE 3 0.0009
212 PREGNANCY 18 0.0009
213 PRODUCT LABEL ISSUE 6 0.0009
214 ACNE 67 0.0009
215 MATERNAL EXPOSURE DURING PREGNANCY 78 0.0009
216 EYELID DISORDER 2 0.0009
217 IMPLANT SITE INFECTION 2 0.0009
218 MYDRIASIS 11 0.0009
219 PERFORMANCE STATUS DECREASED 4 0.0009
220 EAR PRURITUS 3 0.0009
221 CRYING 31 0.0009
222 PULSE ABSENT 4 0.0008
223 PHARYNGITIS STREPTOCOCCAL 9 0.0008
224 VULVOVAGINAL PAIN 4 0.0008
225 RASH VESICULAR 4 0.0008
226 HALLUCINATION, AUDITORY 13 0.0008
227 INJECTION SITE URTICARIA 20 0.0008
228 SENSITIVE SKIN 6 0.0008
229 EMOTIONAL DISORDER 25 0.0008
230 FOOT OPERATION 4 0.0008
231 INTENTIONAL DOSE OMISSION 23 0.0008
232 NEURODERMATITIS 3 0.0008
233 MATERNAL EXPOSURE TIMING UNSPECIFIED 3 0.0008
234 AUTOIMMUNE THYROIDITIS 3 0.0008
235 HUNGER 11 0.0008
236 CHEMICAL BURN OF SKIN 2 0.0008
237 EXPOSURE DURING PREGNANCY 49 0.0008
238 DEPRESSION 177 0.0008
239 CONCUSSION 6 0.0008
240 CARDIAC FLUTTER 5 0.0008
241 LIP DRY 7 0.0008
242 HIDRADENITIS 7 0.0008
243 AFFECTIVE DISORDER 6 0.0008
244 EXFOLIATIVE RASH 2 0.0008
245 SCAR 13 0.0008
246 NYSTAGMUS 4 0.0008
247 POST-TRAUMATIC STRESS DISORDER 5 0.0007
248 SKIN HAEMORRHAGE 11 0.0007
249 ANAL ABSCESS 4 0.0007
250 ANXIETY 211 0.0007
251 GALLBLADDER OPERATION 3 0.0007
252 COLITIS ISCHAEMIC 5 0.0007
253 HOMICIDAL IDEATION 3 0.0007
254 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 4 0.0007
255 GOITRE 3 0.0007
256 EYE MOVEMENT DISORDER 5 0.0007
257 ANAPHYLACTOID REACTION 3 0.0007
258 DROOLING 5 0.0007
259 EMBEDDED DEVICE 7 0.0007
260 CHOLECYSTITIS ACUTE 4 0.0007
261 CHAPPED LIPS 3 0.0007
262 SKIN WARM 4 0.0007
263 IMMOBILE 3 0.0007
264 PROCEDURAL PAIN 19 0.0007
265 HYPERTRIGLYCERIDAEMIA 4 0.0007
266 SLEEP APNOEA SYNDROME 13 0.0007
267 RHINITIS ALLERGIC 3 0.0007
268 FEELING DRUNK 5 0.0007
269 THROMBOSIS 54 0.0007
270 FOREIGN BODY IN REPRODUCTIVE TRACT 6 0.0007
271 MIGRAINE 64 0.0007
272 PAPILLOEDEMA 3 0.0007
273 DISSOCIATION 5 0.0007
274 DUODENITIS 2 0.0007
275 ECTOPIC PREGNANCY 2 0.0006
276 FIBROSIS 2 0.0006
277 ECZEMA 34 0.0006
278 DECREASED ACTIVITY 7 0.0006
279 FAMILY STRESS 2 0.0006
280 FEELING OF DESPAIR 3 0.0006
281 MIDDLE INSOMNIA 12 0.0006
282 PULMONARY THROMBOSIS 7 0.0006
283 YELLOW SKIN 3 0.0006
284 MULTIPLE ALLERGIES 5 0.0006
285 VAGINAL INFECTION 3 0.0006
286 PRODUCT DOSE OMISSION IN ERROR 18 0.0006
287 PRE-ECLAMPSIA 3 0.0006
288 OBSESSIVE-COMPULSIVE DISORDER 5 0.0006
289 SUICIDAL IDEATION 57 0.0006
290 EYE INFECTION 7 0.0006
291 INCOHERENT 4 0.0006
292 DERMATITIS CONTACT 7 0.0006
293 THERAPY CHANGE 6 0.0006
294 APPLICATION SITE BURN 3 0.0006
295 COMPLICATION OF DEVICE REMOVAL 11 0.0006
296 MUCOUS STOOLS 3 0.0006
297 BREAST MASS 4 0.0006
298 VULVOVAGINAL PRURITUS 3 0.0006
299 ANGER 20 0.0006
300 EYE SWELLING 22 0.0006
301 PRODUCT QUALITY ISSUE 80 0.0006
302 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 4 0.0006
303 IMPAIRED GASTRIC EMPTYING 8 0.0006
304 VITAMIN D DECREASED 5 0.0006
305 PRODUCT TEMPERATURE EXCURSION ISSUE 3 0.0006
306 CENTRAL NERVOUS SYSTEM LESION 8 0.0006
307 SKIN HYPERPIGMENTATION 5 0.0006
308 ABNORMAL DREAMS 16 0.0006
309 DEPRESSION SUICIDAL 2 0.0006
310 HYSTERECTOMY 5 0.0006
311 MICTURITION DISORDER 2 0.0006
312 ABORTION SPONTANEOUS 23 0.0006
313 GROIN PAIN 5 0.0006
314 DISEASE RECURRENCE 27 0.0006
315 COLD SWEAT 10 0.0006
316 HEART DISEASE CONGENITAL 2 0.0006
317 CYST 7 0.0006
318 SKIN FISSURES 11 0.0006
319 INJECTION SITE DISCOLOURATION 7 0.0006
320 ABDOMINAL PAIN UPPER 115 0.0006
321 POOR QUALITY SLEEP 12 0.0006
322 IMPAIRED QUALITY OF LIFE 8 0.0006
323 PRODUCT RESIDUE PRESENT 3 0.0006
324 ABDOMINAL DISTENSION 58 0.0006
325 MUSCLE TIGHTNESS 9 0.0006
326 PRURITUS GENERALISED 12 0.0006
327 DEVICE DISLOCATION 24 0.0006
328 MENTAL DISORDER 24 0.0006
329 MONOCYTE COUNT INCREASED 2 0.0006
330 OPTIC NEURITIS 5 0.0005
331 TIC 3 0.0005
332 INJECTION SITE IRRITATION 7 0.0005
333 INJECTION SITE SWELLING 42 0.0005
334 FAECALOMA 3 0.0005
335 UTERINE LEIOMYOMA 4 0.0005
336 DISCOMFORT 33 0.0005
337 DRUG DOSE OMISSION 89 0.0005
338 INJECTION SITE WARMTH 11 0.0005
339 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 38 0.0005
340 NAUSEA 422 0.0005
341 IMPAIRED DRIVING ABILITY 6 0.0005
342 FACE INJURY 2 0.0005
343 COMMUNICATION DISORDER 2 0.0005
344 PARANOIA 9 0.0005
345 QUALITY OF LIFE DECREASED 7 0.0005
346 ENTEROCOLITIS 3 0.0005
347 IRRITABILITY 31 0.0005
348 APNOEA 4 0.0005
349 IRRITABLE BOWEL SYNDROME 11 0.0005
350 FUNGAL INFECTION 17 0.0005
351 ENERGY INCREASED 3 0.0005
352 SINUS HEADACHE 3 0.0005
353 SINUS DISORDER 10 0.0005
354 THIRST 9 0.0005
355 OBESITY 8 0.0005
356 FLUSHING 51 0.0005
357 VOMITING 234 0.0005
358 INJECTION SITE VESICLES 3 0.0005
359 FUNGAL SKIN INFECTION 2 0.0005
360 FRUSTRATION TOLERANCE DECREASED 4 0.0005
361 PRODUCT ADMINISTRATION ERROR 10 0.0005
362 TENSION 3 0.0005
363 APPLICATION SITE DISCOLOURATION 2 0.0005
364 URTICARIA 82 0.0005
365 ENCEPHALOPATHY 12 0.0005
366 ESCHERICHIA INFECTION 4 0.0005
367 COMPLICATION ASSOCIATED WITH DEVICE 7 0.0005
368 EMBOLISM 4 0.0005
369 EYE DISCHARGE 5 0.0005
370 NASAL DRYNESS 3 0.0005
371 WEIGHT FLUCTUATION 5 0.0005
372 SWELLING OF EYELID 3 0.0005
373 INJECTION SITE PRURITUS 32 0.0005
374 ATRIAL SEPTAL DEFECT 4 0.0005
375 MUSCLE TWITCHING 11 0.0005
376 BLEPHAROSPASM 3 0.0005
377 SWELLING FACE 31 0.0005
378 ATTENTION DEFICIT HYPERACTIVITY DISORDER 2 0.0005
379 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
380 RETCHING 10 0.0005
381 MULTIPLE SCLEROSIS RELAPSE 32 0.0005
382 ABNORMAL SENSATION IN EYE 2 0.0005
383 POOR QUALITY DRUG ADMINISTERED 3 0.0005
384 PSYCHOLOGICAL TRAUMA 4 0.0005
385 MUSCLE STRAIN 4 0.0005
386 PALPITATIONS 54 0.0005
387 TOXIC EPIDERMAL NECROLYSIS 7 0.0005
388 SURGERY 27 0.0005
389 ABDOMINAL PAIN 107 0.0005
390 RESPIRATORY SYNCYTIAL VIRUS INFECTION 4 0.0005
391 POLYP 3 0.0005
392 DRUG DISPENSING ERROR 7 0.0005
393 HEADACHE 284 0.0005
394 APPETITE DISORDER 3 0.0005
395 THERAPEUTIC RESPONSE SHORTENED 15 0.0005
396 NERVE INJURY 5 0.0004
397 THERAPY CESSATION 23 0.0004
398 FEAR 12 0.0004
399 PRODUCT TASTE ABNORMAL 6 0.0004
400 GASTROENTERITIS VIRAL 8 0.0004
401 DRUG EFFECT DELAYED 2 0.0004
402 RESTLESS LEGS SYNDROME 8 0.0004
403 MATERNAL EXPOSURE BEFORE PREGNANCY 3 0.0004
404 HAEMOGLOBIN INCREASED 2 0.0004
405 DISEASE COMPLICATION 2 0.0004
406 NIGHTMARE 15 0.0004
407 FORMICATION 3 0.0004
408 APHONIA 6 0.0004
409 EXTRASYSTOLES 3 0.0004
410 CAESAREAN SECTION 5 0.0004
411 DEFAECATION URGENCY 3 0.0004
412 RIGHT VENTRICULAR FAILURE 3 0.0004
413 PHOTOPHOBIA 8 0.0004
414 MUSCLE SPASMS 78 0.0004
415 BLOOD PROLACTIN INCREASED 2 0.0004
416 SEASONAL ALLERGY 6 0.0004
417 PHOTOSENSITIVITY REACTION 7 0.0004
418 INJECTION SITE RASH 13 0.0004
419 PRODUCT DOSE OMISSION ISSUE 124 0.0004
420 DRY SKIN 56 0.0004
421 ACCIDENT 5 0.0004
422 RASH ERYTHEMATOUS 20 0.0004
423 VISUAL FIELD DEFECT 3 0.0004
424 ORAL HERPES 8 0.0004
425 SINUSITIS 42 0.0004
426 PHARYNGEAL SWELLING 4 0.0004
427 CYSTITIS 13 0.0004
428 DISTURBANCE IN ATTENTION 22 0.0004
429 INJECTION SITE REACTION 28 0.0004
430 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 73 0.0004
431 ACTIVITIES OF DAILY LIVING IMPAIRED 8 0.0004
432 HEART RATE INCREASED 40 0.0004
433 ANEURYSM 2 0.0004
434 INJECTION SITE INFLAMMATION 2 0.0004
435 THERAPEUTIC RESPONSE UNEXPECTED 18 0.0004
436 HOT FLUSH 30 0.0004
437 SLEEP DISORDER 28 0.0004
438 PRODUCT PHYSICAL ISSUE 8 0.0004
439 BLOOD TRIGLYCERIDES INCREASED 7 0.0004
440 FEEDING DISORDER 8 0.0004
441 ABDOMINAL DISCOMFORT 66 0.0004
442 NO ADVERSE EVENT 71 0.0004
443 MATERNAL DRUGS AFFECTING FOETUS 3 0.0004
444 DEVICE ISSUE 35 0.0004
445 SKIN DISORDER 13 0.0004
446 EAR DISCOMFORT 4 0.0004
447 EMOTIONAL DISTRESS 47 0.0004
448 FEELING ABNORMAL 93 0.0004
449 TEMPERATURE INTOLERANCE 4 0.0004
450 INJECTION SITE ERYTHEMA 48 0.0004
451 APHTHOUS ULCER 3 0.0004
452 HYPERSOMNIA 11 0.0004
453 PULMONARY HAEMORRHAGE 3 0.0004
454 MALABSORPTION 2 0.0004
455 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
456 DRUG EXPOSURE DURING PREGNANCY 13 0.0004
457 DERMATITIS 8 0.0004
458 PARAESTHESIA 60 0.0004
459 WITHDRAWAL SYNDROME 16 0.0004
460 DRY EYE 19 0.0004
461 ANHEDONIA 10 0.0004
462 PRURITUS 146 0.0004
463 ANKYLOSING SPONDYLITIS 5 0.0004
464 GASTRIC DISORDER 13 0.0004
465 INJECTION SITE MASS 14 0.0004
466 FURUNCLE 3 0.0004
467 ADVERSE REACTION 5 0.0004
468 EAR INFECTION 10 0.0004
469 THINKING ABNORMAL 7 0.0004
470 FOOD POISONING 2 0.0004
471 INJECTION SITE DISCHARGE 2 0.0004
472 PRODUCT USE IN UNAPPROVED INDICATION 92 0.0004
473 WEIGHT INCREASED 83 0.0004
474 PRODUCT PRESCRIBING ISSUE 8 0.0004
475 ABNORMAL FAECES 3 0.0004
476 RASH 159 0.0004
477 APHASIA 11 0.0004
478 VISION BLURRED 50 0.0004
479 HAIR DISORDER 3 0.0004
480 ASTHENOPIA 2 0.0004
481 CHOKING SENSATION 2 0.0004
482 VIRAL INFECTION 12 0.0004
483 ILLNESS 37 0.0004
484 LIVE BIRTH 3 0.0004
485 COLITIS ULCERATIVE 16 0.0004
486 NECK PAIN 20 0.0004
487 KIDNEY INFECTION 7 0.0004
488 SENSATION OF FOREIGN BODY 3 0.0004
489 REBOUND EFFECT 4 0.0004
490 PSORIASIS 46 0.0004
491 GRANULOCYTOPENIA 2 0.0004
492 CHEST PAIN 65 0.0004
493 CONVULSION 20 0.0003
494 SOMNOLENCE 70 0.0003
495 TREATMENT NONCOMPLIANCE 19 0.0003
496 DRUG INTERACTION 55 0.0003
497 PARAESTHESIA ORAL 5 0.0003
498 MOUTH SWELLING 2 0.0003
499 OROPHARYNGEAL PAIN 32 0.0003
500 UNEVALUABLE EVENT 26 0.0003
501 POST PROCEDURAL HAEMORRHAGE 4 0.0003
502 APATHY 5 0.0003
503 GASTRITIS 9 0.0003
504 SPINAL OSTEOARTHRITIS 3 0.0003
505 HYPOAESTHESIA 51 0.0003
506 DEPRESSED MOOD 18 0.0003
507 NASAL CONGESTION 20 0.0003
508 PAIN 209 0.0003
509 LYMPHOCYTE COUNT DECREASED 6 0.0003
510 HYPERSENSITIVITY 63 0.0003
511 INJECTION SITE PAIN 104 0.0003
512 PSYCHOTIC DISORDER 10 0.0003
513 INJECTION SITE BRUISING 27 0.0003
514 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
515 DRUG EFFECT LESS THAN EXPECTED 5 0.0003
516 BLOOD IRON DECREASED 4 0.0003
517 ROAD TRAFFIC ACCIDENT 14 0.0003
518 THROAT IRRITATION 15 0.0003
519 LOSS OF LIBIDO 3 0.0003
520 TOOTHACHE 6 0.0003
521 LUPUS-LIKE SYNDROME 3 0.0003
522 PALLOR 9 0.0003
523 ECONOMIC PROBLEM 5 0.0003
524 NOCTURIA 4 0.0003
525 NEURALGIA 8 0.0003
526 VERTIGO 20 0.0003
527 RESTLESSNESS 12 0.0003
528 JOINT INJURY 7 0.0003
529 INSURANCE ISSUE 5 0.0003
530 DIZZINESS 163 0.0003
531 MENISCUS INJURY 2 0.0003
532 PHARYNGEAL OEDEMA 5 0.0003
533 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
534 CONJUNCTIVITIS 6 0.0003
535 ALOPECIA 63 0.0003
536 DEVICE BREAKAGE 13 0.0003
537 NASOPHARYNGITIS 59 0.0003
538 FLANK PAIN 3 0.0003
539 SKIN EXFOLIATION 27 0.0003
540 INTENTIONAL PRODUCT MISUSE 28 0.0003
541 INFUSION SITE SWELLING 2 0.0003
542 FATIGUE 247 0.0003
543 OCULAR HYPERAEMIA 15 0.0003
544 RASH MACULAR 11 0.0003
545 COVID-19 55 0.0003
546 EYE IRRITATION 18 0.0003
547 ENTERITIS 2 0.0003
548 CHEST DISCOMFORT 32 0.0003
549 LOSS OF CONSCIOUSNESS 40 0.0003
550 ADVERSE DRUG REACTION 28 0.0003
551 PANCREATITIS ACUTE 7 0.0003
552 INFUSION SITE PAIN 4 0.0003
553 NIGHT SWEATS 10 0.0003
554 CHROMATURIA 7 0.0003
555 HIATUS HERNIA 4 0.0003
556 EAR PAIN 6 0.0003
557 INFLAMMATORY BOWEL DISEASE 3 0.0003
558 BRADYPHRENIA 2 0.0003
559 SKIN IRRITATION 14 0.0003
560 HEPATOMEGALY 3 0.0003
561 MANIA 5 0.0003
562 DYSGRAPHIA 2 0.0003
563 UPPER RESPIRATORY TRACT INFECTION 14 0.0003
564 SARS-COV-2 TEST POSITIVE 4 0.0003
565 DISORIENTATION 12 0.0003
566 BLADDER DISORDER 3 0.0003
567 EYE PAIN 17 0.0003
568 VISUAL IMPAIRMENT 37 0.0003
569 LACRIMATION INCREASED 9 0.0003
570 EYE PRURITUS 10 0.0003
571 PAIN OF SKIN 8 0.0003
572 INTENTIONAL PRODUCT USE ISSUE 26 0.0003
573 FREQUENT BOWEL MOVEMENTS 8 0.0003
574 LETHARGY 17 0.0003
575 HYPERHIDROSIS 38 0.0003
576 FLUID RETENTION 15 0.0003
577 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
578 ABNORMAL LOSS OF WEIGHT 2 0.0003
579 INFARCTION 2 0.0003
580 AMNESIA 19 0.0003
581 CROHN'S DISEASE 2 0.0003
582 ECCHYMOSIS 2 0.0003
583 LARGE INTESTINE POLYP 2 0.0003
584 TENDERNESS 3 0.0003
585 POLLAKIURIA 12 0.0003
586 MASS 4 0.0003
587 INJECTION SITE DISCOMFORT 3 0.0003
588 MOUTH ULCERATION 6 0.0003
589 POOR QUALITY PRODUCT ADMINISTERED 3 0.0003
590 RENAL PAIN 3 0.0003
591 PAIN IN JAW 8 0.0003
592 HAND FRACTURE 2 0.0003
593 BLOOD PRESSURE INCREASED 43 0.0003
594 FEAR OF INJECTION 2 0.0003
595 ISCHAEMIC STROKE 5 0.0003
596 HEREDITARY ANGIOEDEMA 3 0.0003
597 INFLUENZA LIKE ILLNESS 23 0.0003
598 PARALYSIS 4 0.0003
599 RASH PRURITIC 15 0.0003
600 MEMORY IMPAIRMENT 38 0.0003
601 SKIN LACERATION 3 0.0003
602 INJECTION SITE HAEMATOMA 4 0.0003
603 INTERVERTEBRAL DISC PROTRUSION 6 0.0003
604 DYSSTASIA 8 0.0003
605 HYPOPHAGIA 7 0.0003
606 APPLICATION SITE PAIN 6 0.0003
607 ANAPHYLACTIC REACTION 15 0.0003
608 BLINDNESS TRANSIENT 2 0.0003
609 BACK PAIN 63 0.0003
610 MEDICAL DEVICE COMPLICATION 2 0.0003
611 CEREBRAL DISORDER 2 0.0003
612 LIP SWELLING 9 0.0003
613 TACHYCARDIA 24 0.0003
614 URINARY TRACT INFECTION 46 0.0003
615 BACTERIAL INFECTION 5 0.0003
616 RASH PAPULAR 6 0.0003
617 ERYTHEMA 55 0.0003
618 DECREASED APPETITE 62 0.0003
619 JOINT STIFFNESS 7 0.0003
620 SCAB 3 0.0003
621 RHINORRHOEA 17 0.0003
622 MICTURITION URGENCY 3 0.0003
623 BOWEL MOVEMENT IRREGULARITY 2 0.0003
624 DEVICE PHYSICAL PROPERTY ISSUE 2 0.0003
625 SEROTONIN SYNDROME 5 0.0003
626 DRUG PRESCRIBING ERROR 5 0.0003
627 MUSCULOSKELETAL CHEST PAIN 4 0.0003
628 CONGENITAL ANOMALY 2 0.0003
629 DELUSION 4 0.0003
630 BLOOD CHOLESTEROL INCREASED 12 0.0003
631 COGNITIVE DISORDER 12 0.0003
632 BURNING SENSATION 18 0.0003
633 BASAL CELL CARCINOMA 4 0.0003
634 COVID-19 PNEUMONIA 3 0.0003
635 PRODUCT USE COMPLAINT 4 0.0003
636 ABNORMAL BEHAVIOUR 10 0.0003
637 PRODUCT STORAGE ERROR 22 0.0003
638 HYPOTHYROIDISM 8 0.0003
639 CONDITION AGGRAVATED 76 0.0002
640 SENSORY DISTURBANCE 4 0.0002
641 MIOSIS 2 0.0002
642 INFECTION 36 0.0002
643 ASTHMA 28 0.0002
644 ADRENAL INSUFFICIENCY 3 0.0002
645 MUSCLE DISORDER 2 0.0002
646 SCHIZOPHRENIA 3 0.0002
647 PRESYNCOPE 6 0.0002
648 DEVICE EXPULSION 16 0.0002
649 THERAPY NON-RESPONDER 11 0.0002
650 MUSCLE SPASTICITY 3 0.0002
651 INSOMNIA 65 0.0002
652 DYSPHAGIA 23 0.0002
653 GENERALISED TONIC-CLONIC SEIZURE 4 0.0002
654 ACUTE CORONARY SYNDROME 2 0.0002
655 HEMIPLEGIA 2 0.0002
656 AGGRESSION 12 0.0002
657 SKIN DISCOLOURATION 11 0.0002
658 ADVERSE EVENT 22 0.0002
659 DERMATITIS ALLERGIC 3 0.0002
660 THERAPY INTERRUPTED 17 0.0002
661 MALAISE 104 0.0002
662 HALLUCINATION, VISUAL 5 0.0002
663 DEVICE DEPLOYMENT ISSUE 3 0.0002
664 FACIAL PARALYSIS 2 0.0002
665 GASTROINTESTINAL DISORDER 21 0.0002
666 ANOREXIA 3 0.0002
667 ANURIA 2 0.0002
668 INJECTION SITE INDURATION 3 0.0002
669 CARDIAC MURMUR 2 0.0002
670 CHILLS 27 0.0002
671 PLATELET COUNT INCREASED 3 0.0002
672 BRONCHITIS 17 0.0002
673 LOCAL SWELLING 4 0.0002
674 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 11 0.0002
675 EPILEPSY 7 0.0002
676 FEELING HOT 14 0.0002
677 INCORRECT PRODUCT STORAGE 3 0.0002
678 SEIZURE 26 0.0002
679 HAIR TEXTURE ABNORMAL 3 0.0002
680 JOINT RANGE OF MOTION DECREASED 3 0.0002
681 THERAPEUTIC PRODUCT EFFECT DECREASED 10 0.0002
682 HAEMARTHROSIS 2 0.0002
683 SNEEZING 5 0.0002
684 DRUG EFFECT DECREASED 12 0.0002
685 MOBILITY DECREASED 16 0.0002
686 SINUS CONGESTION 3 0.0002
687 TACHYPNOEA 3 0.0002
688 HAEMORRHAGE 23 0.0002
689 MUSCULAR WEAKNESS 25 0.0002
690 SYNCOPE 22 0.0002
691 BALANCE DISORDER 19 0.0002
692 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 12 0.0002
693 PRODUCT USE ISSUE 41 0.0002
694 MOVEMENT DISORDER 7 0.0002
695 DYSURIA 8 0.0002
696 GRAND MAL CONVULSION 2 0.0002
697 CONSTIPATION 47 0.0002
698 INFLUENZA 24 0.0002
699 COORDINATION ABNORMAL 3 0.0002
700 THERAPEUTIC RESPONSE DECREASED 13 0.0002
701 CARPAL TUNNEL SYNDROME 3 0.0002
702 DEFORMITY 2 0.0002
703 EYE DISORDER 7 0.0002
704 INJECTION SITE HAEMORRHAGE 17 0.0002
705 LYMPHOPENIA 3 0.0002
706 GASTROOESOPHAGEAL REFLUX DISEASE 17 0.0002
707 BLOOD URINE PRESENT 4 0.0002
708 NERVOUSNESS 11 0.0002
709 MUSCULOSKELETAL DISORDER 4 0.0002
710 MUSCULOSKELETAL PAIN 11 0.0002
711 SPEECH DISORDER 11 0.0002
712 PRODUCT PRESCRIBING ERROR 5 0.0002
713 FEELING JITTERY 4 0.0002
714 RED BLOOD CELL COUNT DECREASED 6 0.0002
715 BLOOD PRESSURE FLUCTUATION 5 0.0002
716 TYPE 2 DIABETES MELLITUS 7 0.0002
717 ANOSMIA 3 0.0002
718 PAIN IN EXTREMITY 61 0.0002
719 LOCALISED INFECTION 5 0.0002
720 ERUCTATION 4 0.0002
721 DIZZINESS POSTURAL 2 0.0002
722 DYSTONIA 4 0.0002
723 HEPATIC ENZYME INCREASED 14 0.0002
724 AUTOIMMUNE DISORDER 2 0.0002
725 CHOKING 4 0.0002
726 TREMOR 34 0.0002
727 DRUG INEFFECTIVE 269 0.0002
728 ACUTE MYOCARDIAL INFARCTION 6 0.0002
729 KNEE OPERATION 2 0.0002
730 DYSPEPSIA 20 0.0002
731 DIARRHOEA 131 0.0002
732 DISABILITY 4 0.0002
733 INABILITY TO AFFORD MEDICATION 2 0.0002
734 IMMUNODEFICIENCY 3 0.0002
735 BRAIN INJURY 2 0.0002
736 HEART RATE DECREASED 7 0.0002
737 INTENTIONAL SELF-INJURY 4 0.0002
738 EXTRA DOSE ADMINISTERED 8 0.0002
739 CONTUSION 19 0.0002
740 SYSTEMIC LUPUS ERYTHEMATOSUS 7 0.0002
741 INCORRECT DOSE ADMINISTERED 45 0.0002
742 DYSKINESIA 8 0.0002
743 MOTOR DYSFUNCTION 2 0.0002
744 NEPHROLITHIASIS 9 0.0002
745 TINNITUS 9 0.0002
746 EUPHORIC MOOD 2 0.0002
747 THYROID DISORDER 3 0.0002
748 RIB FRACTURE 4 0.0002
749 LIMB DISCOMFORT 6 0.0002
750 ANKLE FRACTURE 3 0.0002
751 INFLAMMATION 10 0.0002
752 WEIGHT DECREASED 54 0.0002
753 DRUG EFFECT INCOMPLETE 7 0.0002
754 WRONG TECHNIQUE IN DRUG USAGE PROCESS 7 0.0002
755 SWOLLEN TONGUE 6 0.0002
756 BRAIN FOG 3 0.0002
757 DYSPNOEA 107 0.0002
758 COUGH 53 0.0002
759 ULCER 3 0.0002
760 PRODUCTIVE COUGH 9 0.0002
761 METABOLIC ACIDOSIS 6 0.0002
762 EPISTAXIS 14 0.0002
763 BREAST CANCER METASTATIC 2 0.0002
764 JAUNDICE 5 0.0002
765 INTESTINAL OBSTRUCTION 7 0.0002
766 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
767 BACK DISORDER 3 0.0002
768 HYPERTENSION 39 0.0002
769 BACK INJURY 2 0.0002
770 PRODUCT DISPENSING ERROR 4 0.0002
771 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
772 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 13 0.0002
773 MUSCULOSKELETAL STIFFNESS 16 0.0002
774 ASPIRATION 2 0.0002
775 INJECTION SITE NODULE 2 0.0002
776 SWELLING 17 0.0002
777 DENTAL CARIES 2 0.0002
778 COAGULOPATHY 3 0.0002
779 MENTAL STATUS CHANGES 5 0.0002
780 TRANSAMINASES INCREASED 4 0.0002
781 FEELING COLD 5 0.0002
782 GAIT INABILITY 6 0.0002
783 ORAL PAIN 4 0.0002
784 INTESTINAL PERFORATION 2 0.0002
785 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
786 FLATULENCE 10 0.0002
787 PRODUCT AVAILABILITY ISSUE 4 0.0002
788 PERIPHERAL SWELLING 27 0.0002
789 ANGINA PECTORIS 5 0.0002
790 GENERAL PHYSICAL HEALTH DETERIORATION 20 0.0002
791 MADAROSIS 2 0.0002
792 EYELID OEDEMA 2 0.0002
793 DEVICE USE ISSUE 3 0.0002
794 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
795 HYPOXIA 6 0.0002
796 PANCREATITIS 9 0.0002
797 CARDIAC ARREST 14 0.0002
798 HEAD DISCOMFORT 3 0.0002
799 WHEEZING 10 0.0002
800 MULTIPLE SCLEROSIS 8 0.0002
801 GAIT DISTURBANCE 32 0.0002
802 BLOOD POTASSIUM DECREASED 5 0.0002
803 LEUKOCYTOSIS 3 0.0002
804 MENTAL IMPAIRMENT 4 0.0002
805 FIBROMYALGIA 4 0.0002
806 CEREBRAL INFARCTION 4 0.0002
807 HAEMATOCHEZIA 9 0.0002
808 CARDIOMEGALY 2 0.0002
809 BLOOD GLUCOSE ABNORMAL 3 0.0002
810 OFF LABEL USE 142 0.0002
811 HYPERCALCAEMIA 2 0.0002
812 ABNORMAL WEIGHT GAIN 2 0.0002
813 ABASIA 4 0.0002
814 HEPATIC STEATOSIS 3 0.0002
815 HAIR COLOUR CHANGES 2 0.0002
816 DRY MOUTH 13 0.0002
817 DRUG-INDUCED LIVER INJURY 5 0.0002
818 COLITIS 6 0.0002
819 PRODUCT COMPLAINT 4 0.0002
820 GASTRIC ULCER 3 0.0002
821 DEHYDRATION 21 0.0002
822 JOINT SWELLING 19 0.0002
823 INCREASED APPETITE 3 0.0002
824 INTRAOCULAR PRESSURE INCREASED 2 0.0002
825 ARTHRALGIA 65 0.0002
826 DIPLOPIA 4 0.0002
827 RESPIRATORY TRACT INFECTION 4 0.0002
828 PYREXIA 53 0.0002
829 APPLICATION SITE ERYTHEMA 4 0.0002
830 ASTHENIA 57 0.0002
831 STAPHYLOCOCCAL INFECTION 5 0.0002
832 HAEMATOCRIT DECREASED 3 0.0002
833 BLOOD PRESSURE ABNORMAL 3 0.0002
834 PRESCRIBED UNDERDOSE 3 0.0002
835 EYE HAEMORRHAGE 2 0.0001
836 MALIGNANT MELANOMA 2 0.0001
837 THROAT TIGHTNESS 4 0.0001
838 PSORIATIC ARTHROPATHY 6 0.0001
839 BLINDNESS 6 0.0001
840 BODY TEMPERATURE INCREASED 3 0.0001
841 ACUTE HEPATIC FAILURE 2 0.0001
842 PRODUCT PREPARATION ERROR 3 0.0001
843 SKIN LESION 4 0.0001
844 APPLICATION SITE RASH 2 0.0001
845 HAEMOPTYSIS 4 0.0001
846 OXYGEN SATURATION DECREASED 8 0.0001
847 OSTEOARTHRITIS 6 0.0001
848 LYMPHADENOPATHY 5 0.0001
849 EATING DISORDER 3 0.0001
850 BRONCHOSPASM 2 0.0001
851 LIVER FUNCTION TEST INCREASED 3 0.0001
852 OEDEMA PERIPHERAL 17 0.0001
853 CELLULITIS 7 0.0001
854 FAECES DISCOLOURED 3 0.0001
855 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 28 0.0001
856 HYPERTHYROIDISM 2 0.0001
857 HYPOKINESIA 2 0.0001
858 NEEDLE ISSUE 4 0.0001
859 DEVICE DIFFICULT TO USE 9 0.0001
860 CEREBROVASCULAR ACCIDENT 23 0.0001
861 LABORATORY TEST ABNORMAL 4 0.0001
862 TOOTH DISORDER 3 0.0001
863 HEART RATE IRREGULAR 3 0.0001
864 HYPOAESTHESIA ORAL 2 0.0001
865 CONTRAINDICATED PRODUCT ADMINISTERED 4 0.0001
866 SUICIDE ATTEMPT 8 0.0001
867 ASPARTATE AMINOTRANSFERASE INCREASED 7 0.0001
868 DRUG ADMINISTRATION ERROR 4 0.0001
869 DEVICE RELATED INFECTION 2 0.0001
870 MYALGIA 22 0.0001
871 NERVOUS SYSTEM DISORDER 4 0.0001
872 HEAD INJURY 4 0.0001
873 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
874 ANAEMIA 24 0.0001
875 SKIN BURNING SENSATION 9 0.0001
876 CONFUSIONAL STATE 20 0.0001
877 HOSPITALISATION 19 0.0001
878 RHEUMATOID ARTHRITIS 14 0.0001
879 LUNG DISORDER 6 0.0001
880 INFUSION RELATED REACTION 8 0.0001
881 AGEUSIA 3 0.0001
882 HEMIPARESIS 2 0.0001
883 DRUG RESISTANCE 3 0.0001
884 RECTAL HAEMORRHAGE 5 0.0001
885 ANAPHYLACTIC SHOCK 3 0.0001
886 UNRESPONSIVE TO STIMULI 3 0.0001
887 RASH GENERALISED 3 0.0001
888 NEUROPATHY PERIPHERAL 11 0.0001
889 STOMATITIS 7 0.0001
890 DEVICE DEFECTIVE 2 0.0001
891 DELIRIUM 4 0.0001
892 FALL 38 0.0001
893 BLOOD BILIRUBIN INCREASED 3 0.0001
894 OEDEMA 6 0.0001
895 LIMB INJURY 3 0.0001
896 DEVICE DELIVERY SYSTEM ISSUE 3 0.0001
897 RESPIRATORY ARREST 3 0.0001
898 RESPIRATORY DISTRESS 3 0.0001
899 DYSGEUSIA 8 0.0001
900 BLISTER 6 0.0001
901 DYSARTHRIA 4 0.0001
902 HYPOCALCAEMIA 2 0.0001
903 ARRHYTHMIA 5 0.0001
904 FOOT FRACTURE 2 0.0001
905 HERPES ZOSTER 6 0.0001
906 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
907 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
908 CHOLESTASIS 2 0.0001
909 HERNIA 2 0.0001
910 HAEMORRHOIDS 2 0.0001
911 BONE PAIN 6 0.0001
912 ASCITES 3 0.0001
913 RESPIRATORY DISORDER 3 0.0001
914 PREMATURE BABY 3 0.0001
915 INJURY ASSOCIATED WITH DEVICE 2 0.0001
916 ALANINE AMINOTRANSFERASE INCREASED 6 0.0001
917 AGITATION 7 0.0001
918 DRUG INTOLERANCE 9 0.0001
919 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
920 IMPAIRED HEALING 3 0.0001
921 ANGIOEDEMA 4 0.0001
922 VISUAL ACUITY REDUCED 3 0.0001
923 EXPIRED PRODUCT ADMINISTERED 3 0.0001
924 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
925 URINARY RETENTION 3 0.0001
926 GLOSSODYNIA 2 0.0001
927 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
928 HAEMATURIA 3 0.0001
929 TREATMENT FAILURE 7 0.0001
930 CEREBRAL HAEMORRHAGE 3 0.0001
931 HYPOGLYCAEMIA 4 0.0001
932 HYPERGLYCAEMIA 3 0.0001
933 UNDERDOSE 6 0.0001
934 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
935 HALLUCINATION 6 0.0001
936 HAEMATEMESIS 2 0.0001
937 DIABETES MELLITUS 6 0.0001
938 ACCIDENTAL EXPOSURE TO PRODUCT 8 0.0001
939 PNEUMONIA 25 0.0001
940 EXPOSURE VIA SKIN CONTACT 2 0.0001
941 PLATELET COUNT DECREASED 8 0.0001
942 BREAST CANCER FEMALE 2 0.0001
943 WHITE BLOOD CELL COUNT DECREASED 8 0.0001
944 SEPTIC SHOCK 3 0.0001
945 DRUG WITHDRAWAL SYNDROME 6 0.0001
946 LIVER DISORDER 3 0.0001
947 CHRONIC KIDNEY DISEASE 5 0.0001
948 PLEURAL EFFUSION 4 0.0001
949 HYPOKALAEMIA 3 0.0001
950 OVERDOSE 14 0.0001
951 RENAL DISORDER 3 0.0001
952 BREAST CANCER 6 0.0001
953 BONE DENSITY DECREASED 2 0.0001
954 BLOOD GLUCOSE DECREASED 3 0.0001
955 BLOOD PRESSURE DECREASED 4 0.0001
956 DRUG ABUSE 5 0.0001
957 HYPOTENSION 12 0.0001
958 ACUTE KIDNEY INJURY 9 0.0001
959 HAEMOGLOBIN DECREASED 6 0.0001
960 DEVICE MALFUNCTION 4 0.0001
961 BRADYCARDIA 3 0.0001
962 C-REACTIVE PROTEIN INCREASED 2 0.0001
963 RESPIRATORY FAILURE 4 0.0001
964 SEPSIS 6 0.0001
965 DYSPNOEA EXERTIONAL 2 0.0001
966 ARTHRITIS 4 0.0001
967 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
968 INTENTIONAL OVERDOSE 3 0.0000
969 HYPOACUSIS 2 0.0000
970 DEVICE LEAKAGE 2 0.0000
971 BLOOD CREATININE INCREASED 3 0.0000
972 FEBRILE NEUTROPENIA 3 0.0000
973 COMA 2 0.0000
974 INTERSTITIAL LUNG DISEASE 2 0.0000
975 DRUG DEPENDENCE 6 0.0000
976 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
977 NEUTROPENIA 5 0.0000
978 DEPENDENCE 2 0.0000
979 ARTHROPATHY 2 0.0000
980 MEDICATION ERROR 2 0.0000
981 THROMBOCYTOPENIA 4 0.0000
982 DYSPHONIA 2 0.0000
983 ILL-DEFINED DISORDER 2 0.0000
984 CARDIAC DISORDER 3 0.0000
985 BLOOD GLUCOSE INCREASED 6 0.0000
986 TOXICITY TO VARIOUS AGENTS 5 0.0000
987 DRUG DOSE OMISSION BY DEVICE 2 0.0000
988 MYOCARDIAL INFARCTION 4 0.0000
989 ATRIAL FIBRILLATION 2 0.0000
990 DEATH 10 0.0000